Genome Editing Market By Delivery Method (Ex-vivo and In-vivo), By Technology (CRISPR/Cas9, Meganuclease, TALENs/MegaTALs, ZFN, and Others), By Application (Genetic Engineering (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering, and Others) and Clinical Applications (Diagnostics and Therapy Development)), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview The Global Genome Editing Market Size is expected to be worth around US$ 44.4 Billion by 2034, from US$ 9.4 Billion in 2024, growing at a CAGR of 16.8% during the for...